NICHD conducts and supports a variety of clinical research related to muscular dystrophy. Select one of the following links to learn more about these projects.
- Skeletal Muscle Biomarkers in People with Fragile Sarcolemmal Muscular Dystrophy (FSMD)
This study examines blood samples of people with FSMD to identify changes in several muscle enzymes that may serve as biomarkers for the FSMD disease process. FSMD makes the skeletal muscle membrane more fragile, affecting how the muscles contract and relax, which causes mobility problems. Identifying biomarkers for FSMD may lead to better treatments for this condition.
Select one of the following links to view ClinicalTrials.gov search results for studies on muscular dystrophy: